Clinical trial
The Efficacy and Safety of Deep Brain Stimulation of Combined Anterior Limb of Internal Capsule and Nucleus Accumbens (ALIC/NAcc-DBS) for Treatment-refractory Obsessive-compulsive Disorder (OCD)
NCT04967560 is registered in ClinicalTrials.gov with Shanghai Mental Health Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Efficacy and Safety of Deep Brain Stimulation of Combined Anterior Limb of Internal Capsule and Nucleus Accumbens (ALIC/NAcc-DBS) for Treatment-refractory Obsessive-compulsive Disorder (OCD)
- Lead sponsor
- Shanghai Mental Health Center
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- July 30, 2021
- Completion date
- January 29, 2024
- Enrollment
- 60 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.